Medical Editor: John P. Cunha, DO, FACOEP
Acetazolamide for Injection is an inhibitor of the enzyme carbonic anhydrase used to treat edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Acetazolamide for injection is available in generic form. Common side effects of acetazolamide for injection include "tingling" feeling in the extremities, hearing problems or ringing in the ears (tinnitus), loss of appetite, changes in taste, nausea, vomiting, diarrhea, excessive urination, drowsiness, fatigue, general feeling of being unwell (malaise), and confusion.
The dose of acetazolamide depends on the condition being treated. Acetazolamide may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, acetazolamide should be used only if prescribed. Consult your doctor before breastfeeding.
Our Acetazolamide for Injection Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Adverse reactions, occurring most often early in therapy, include paresthesias, particularly a “tingling” feeling in the extremities, hearing dysfunction or tinnitus, loss of appetite, taste alteration and gastrointestinal disturbances such as nausea, vomiting and diarrhea; polyuria, and occasional instances of drowsiness and confusion.
Other occasional adverse reactions include urticaria, melena, hematuria, glycosuria, hepatic insufficiency, flaccid paralysis, photosensitivity and convulsions. Also see PRECAUTIONS: Information for Patients for possible reactions common to sulfonamide derivatives. Fatalities have occurred although rarely, due to severe reactions to sulfonamides including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia and other blood dyscrasias (see WARNINGS).
Read the entire FDA prescribing information for Acetazolamide Injection (Acetazolamide Injection)
© Acetazolamide Injection Patient Information is supplied by Cerner Multum, Inc. and Acetazolamide Injection Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.